“Matt Tong’s ability to find uniquely skilled professionals with deep experience of vector-based gene therapy approaches has played a major part in establishing the leadership group that we have today. Matt’s advanced knowledge of our culture, business strategy and clinical programs has led to impressive placements and therefore is proven to provide us with a competitive advantage over peer companies that are also looking to acquire talent from a small and highly specialist pool.”
Chief R&D Officer.
Scope of work:
Through Matt Tong and his team, critical hires were made within a three-month period to complete an upper leadership group of Gene Tx (AAV & Lenti) experts to enable the company to progress with new programs.
Chief Scientific Officer
Senior Vice President of Technical Operations & CMC:
Senior Vice President of Regulatory Affairs and Quality Assurance.
Once the functional leadership team had been established, Tong’s team continued to support the build out of various groups, including but not limited to:
VP of Technical Operations (AAV)
Head and Analytical Development
SVP Clinical Development
Clinical Physician
Head of Supply Chain
Senior Director of Regulatory Strategy
Senior Director of Process Development.
VP Program Management
Comments